SCHEMBL668000

SCHEMBL668000

CC(NCl)C(O)c1ccc(O)c(O)c1

nearest known ligand 0.73

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 10/20 0.61
▸ TDP1 Q9NUW8 9/20 0.61
▸ MAPT P10636 9/20 0.61
▸ RECQL P46063 5/20 0.61
▸ TSHR P16473 5/20 0.61
▸ HSD17B10 Q99714 5/20 0.61
▸ HIF1A Q16665 5/20 0.61
▸ LMNA P02545 4/20 0.61
▸ MTOR P42345 4/20 0.61
▸ KMT2A Q03164 4/20 0.61
▸ NFKB1 P19838 3/20 0.61
▸ BLM P54132 3/20 0.61
▸ POLB P06746 2/20 0.61
▸ APEX1 P27695 2/20 0.61
▸ THPO P40225 2/20 0.61
▸ ALOX15 P16050 1/20 0.61
▸ ADRB2 P07550 6/20 0.54
▸ PTGS2 P35354 2/20 0.54
▸ OPRK1 P41145 1/20 0.54
▸ SLC6A3 Q01959 1/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Dioxifedrine SCHEMBL250137 0.85 TDP1 (0.61) KDM4ETDP1MAPTRECQLTSHR
Dioxifedrine SCHEMBL364347 0.83 KDM4E (0.62) KDM4ETDP1MAPTRECQLTSHR
Dioxethedrin SCHEMBL249560 0.80 ADRB2 (0.58) KDM4ETDP1MAPTRECQLTSHR
SCHEMBL11279641 0.80 SLC6A4 (0.59) KDM4ETDP1MAPTRECQLTSHR
SCHEMBL14290757 0.79 TDP1 (0.70) KDM4ETDP1MAPTRECQLTSHR
Dioxethedrin SCHEMBL365011 0.79 KDM4E (0.57) KDM4ETDP1MAPTRECQLTSHR
Hydrochloric Acid SCHEMBL11279633 0.79 KDM4E (0.57) KDM4ETDP1MAPTRECQLTSHR
SCHEMBL29102057 0.79 TDP1 (0.68) KDM4ETDP1MAPTRECQLTSHR
SCHEMBL19361289 0.78 ADRB2 (0.55) KDM4ETDP1MAPTRECQLTSHR
SCHEMBL29525823 0.77 TDP1 (0.65) KDM4ETDP1MAPTRECQLTSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 65 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1073470-A1 PHARMACEUTICAL COMPOSITIONS CONTAINING COMPOUNDS WITH ACTIVITY FOR THE ENHANCEMENT OF ABSORPTION OF ACTIVE INGREDIENTS INPHARMA S.A. (CH) 2001-02-07 — — EP claimed
WO-2000048636-A1 PHARMACEUTICAL COMPOSITIONS CONTAINING COMPOUNDS WITH ACTIVITY FOR THE ENHANCEMENT OF ABSORPTION OF ACTIVE INGREDIENTS INPHARMA S.A. (CH) 2000-08-24 — — WO claimed
US-20200197310-A1 Technology for Preparation of Macromolecular Microspheres NEXBIO, INC. 2020-06-25 — — US disclosed
US-10583086-B2 Technology for preparation of macromolecular microspheres ANSUN BIOPHARMA, INC. (US) 2020-03-10 — — US disclosed
US-10231938-B2 Transdermal drug delivery device including an occlusive backing NOVEN PHARMACEUTICALS, INC. (US) 2019-03-19 — — US disclosed
US-20180071219-A1 Technology for Preparation of Macromolecular Microspheres NEXBIO, INC. 2018-03-15 — — US disclosed
US-20180028449-A1 Technology for the Preparation of Microparticles NEXBIO, INC. 2018-02-01 — — US disclosed
US-9682043-B2 Method of preparation of mixed phase co-crystals with active agents MEDCRYSTALFORMS, LLC (US) 2017-06-20 — — US disclosed
US-20170079920-A1 Technology for the Preparation of Microparticles NEXBIO, INC. 2017-03-23 — — US disclosed
US-20160235675-A1 Technology for the Preparation of Microparticles NEXBIO, INC. 2016-08-18 — — US disclosed
EP-1807033-B1 TRANSDERMAL DRUG DELIVERY DEVICE INCLUDING AN OCCLUSIVE BACKING NOVEN PHARMA (US) 2016-07-20 — — EP disclosed
US-6562363-B1 Bioadhesive compositions and methods for topical administration of active agents NOVEN PHARMACEUTICALS, INC. 2003-05-13 — — US disclosed
US-20020004065-A1 Compositions and methods to effect the release profile in the transdermal administration of active agents KANIOS DAVID (US) 2002-01-10 — — US disclosed
US-6221383-B1 BLEND OF AT LEAST TWO POLYMERS, OR AT LEAST ONE POLYMER AND A SOLUBLE POLYVINYLPYRROLIDONE, IN COMBINATION WITH A DRUG PROVIDES A PRESSURE-SENSITIVE ADHESIVE COMPOSITION FOR A TRANSDERMAL DRUG DELIVERY SYSTEM NOVEN PHARMACEUTICALS, INC. 2001-04-24 — — US disclosed
EP-1073470-A1 PHARMACEUTICAL COMPOSITIONS CONTAINING COMPOUNDS WITH ACTIVITY FOR THE ENHANCEMENT OF ABSORPTION OF ACTIVE INGREDIENTS INPHARMA S.A. (CH) 2001-02-07 — — EP disclosed
WO-2000048636-A1 PHARMACEUTICAL COMPOSITIONS CONTAINING COMPOUNDS WITH ACTIVITY FOR THE ENHANCEMENT OF ABSORPTION OF ACTIVE INGREDIENTS INPHARMA S.A. (CH) 2000-08-24 — — WO disclosed
EP-1021204-A2 BIOADHESIVE COMPOSITIONS AND METHODS FOR TOPICAL ADMINISTRATION OF ACTIVE AGENTS NOVEN PHARMACEUTICALS, INC. (US) 2000-07-26 — — EP disclosed
US-6024976-A TRANSDERMAL DRUG DELIVERY WITH PRESSURE SENSITIVE ADHESIVE COMPOSITION OF POLYVINYLPYRROLIDONE WITH DRUG IN MULTILAYER PATCH NOVEN PHARMACEUTICALS, INC. (US) 2000-02-15 — — US disclosed
WO-1999015210-A2 BIOADHESIVE COMPOSITIONS AND METHODS FOR TOPICAL ADMINISTRATION OF ACTIVE AGENTS NOVEN PHARMACEUTICALS, INC. (US) 1999-04-01 — — WO disclosed
US-5656286-A BLEND OF TWO POLYMERS; PRESSURE SENSITIVE ADHESIVE NOVEN PHARMACEUTICALS, INC. (US) 1997-08-12 — — US disclosed
Send feedback